Stem Point Capital LP Merus N.V. Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Merus N.V. stock. As of the latest transaction made, Stem Point Capital LP holds 266,094 shares of MRUS stock, worth $17 Million. This represents 4.49% of its overall portfolio holdings.
Number of Shares
266,094
Previous 346,756
23.26%
Holding current value
$17 Million
Previous $14.6 Billion
4.1%
% of portfolio
4.49%
Previous 4.65%
Shares
7 transactions
Others Institutions Holding MRUS
# of Institutions
211Shares Held
65.4MCall Options Held
287KPut Options Held
575K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$273 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$255 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$238 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$225 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$216 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.93B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...